Synthesis and biological evaluation of 1,3,4-oxadiazole bearing dihydropyrimidines as potential antitubercular agents
- 17 December 2015
- journal article
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 25 (2) , 329-338
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Synthesis, antimicrobial and cytotoxic activities of some novel thiazole clubbed 1,3,4-oxadiazolesEuropean Journal of Medicinal Chemistry, 2013
- Molecular properties prediction and synthesis of novel 1,3,4-oxadiazole analogues as potent antimicrobial and antitubercular agentsBioorganic & Medicinal Chemistry Letters, 2011
- Screening for In Vitro Antimycobacterial Activity and Three‐Dimensional Quantitative Structure–Activity Relationship (3D‐QSAR) Study of 4‐(arylamino)coumarin DerivativesChemical Biology & Drug Design, 2010
- Antioxidant properties of some 5-ethoxycarbonyl-substituted 3,4-dihydropyrimidin-2(1H)-ones (-thiones) and their derivativesRussian Journal of Applied Chemistry, 2010
- Synthesis and pharmacological evaluation of 1,3,4-oxadiazole bearing bis(heterocycle) derivatives as anti-inflammatory and analgesic agentsEuropean Journal of Medicinal Chemistry, 2009
- Design, synthesis and hypolipidemic activity of novel 2-(naphthalen-2-yloxy)propionic acid derivatives as desmethyl fibrate analogsEuropean Journal of Medicinal Chemistry, 2009
- Aroylpropionic acid based 2,5-disubstituted-1,3,4-oxadiazoles: Synthesis and their anti-inflammatory and analgesic activitiesEuropean Journal of Medicinal Chemistry, 2009
- Mycobacterium tuberculosis CYP130Journal of Biological Chemistry, 2008
- Synthesis and anti-inflammatory activity of some [4,6-(4-substituted aryl)-2-thioxo-1,2,3,4-tetrahydro-pyrimidin-5-yl]-acetic acid derivativesBioorganic & Medicinal Chemistry Letters, 2004
- Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugsJournal of Molecular Biology, 2000